SCHEMBL18540809

SCHEMBL18540809

COC(=O)c1cccc(CCCC(=O)CBr)c1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 5/20 0.66
▸ CYP4F2 P78329 4/20 0.66
▸ LOXL2 Q9Y4K0 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.49
▸ FOLH1 Q04609 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ SLC7A5 Q01650 1/20 0.49
▸ MRGPRX4 Q96LA9 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ DHODH Q02127 1/20 0.45
▸ HIF1A Q16665 1/20 0.44
▸ PARP1 P09874 1/20 0.44
▸ FAAH O00519 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19078986 0.85 CYP4A11 (0.78) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL6614812 0.85 CYP4A11 (0.73) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL18540810 0.84 CYP4F2 (0.71) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL19078992 0.84 CYP4A11 (0.76) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL18540808 0.83 CYP4A11 (0.69) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL8921794 0.82 CYP4A11 (0.73) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL244703 0.82 CYP4F2 (0.73) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL70173 0.82 CYP4F2 (0.83) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL1792728 0.81 CYP4A11 (0.75) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1
SCHEMBL10606812 0.81 CYP4A11 (0.75) CYP4A11CYP4F2LOXL2ALDH1A1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994586-B2 Monocyclic, thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of the same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2018-06-12 — — US disclosed
US-9994586-B2 Monocyclic, thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of the same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2018-06-12 — — US disclosed
WO-2017031176-A1 MONOCYCLIC, THIENO, PYRIDO, AND PYRROLO PYRIMIDINE COMPOUNDS AND METHODS OF USE AND MANUFACTURE OF THE SAME DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2017-02-23 — — WO disclosed
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2017-02-23 — — US disclosed
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2017-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same CYP4F3, TYMS, DPYD CYP4A11 443/4885CYP4F2 19/4885LOXL2 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback